Although low cost cards will help alleviate the burden of significant drug expenses in the short term, they do not address the systemic concerns driving up prescription charges while in the U.S. Broader policy improvements could tackle the foundation results in of increasing drug costs, like insufficient transparency in pricing plus the role of int